We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ANIP market cap is 1.37B. The company's latest EPS is USD 0.8138 and P/E is 79.72.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 106.79M | 116.55M | 132.39M | 131.65M | 137.43M |
Operating Income | 9.9M | 12.4M | 15.95M | 8.71M | 15.06M |
Net Income | 1.03M | 5.84M | 9.53M | 749k | 17.8M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 206.55M | 208.48M | 216.14M | 316.39M | 486.82M |
Operating Income | 16.35M | -16.02M | -39.79M | -35.28M | 48.4M |
Net Income | 6.09M | -22.55M | -42.79M | -49.52M | 17.15M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 765.22M | 859.34M | 889.91M | 904.42M | 914.52M |
Total Liabilities | 425.74M | 424.87M | 435.2M | 446.82M | 437.71M |
Total Equity | 314.63M | 409.62M | 429.86M | 432.75M | 451.96M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 456.79M | 461.19M | 771.6M | 760.09M | 904.42M |
Total Liabilities | 244M | 265.49M | 412.86M | 421.55M | 446.82M |
Total Equity | 212.79M | 195.7M | 333.89M | 313.69M | 432.75M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 21.42M | 42.05M | 74.22M | 118.96M | 18.27M |
Investing | -2.35M | -9.18M | -13.73M | -18.51M | 8.93M |
Financing | -4.55M | 75.6M | 79.36M | 67.44M | -19.73M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 45.63M | 15.27M | 3.32M | -31.2M | 118.96M |
Investing | -27.55M | -68.32M | -105.48M | -15.74M | -18.51M |
Financing | 1.25M | -1.44M | 194.6M | -5.13M | 67.44M |
Market Cap | 1.37B |
Price to Earnings Ratio | 79.72 |
Price to Sales Ratio | 2.81 |
Price to Cash Ratio | 6.18 |
Price to Book Ratio | 2.99 |
Dividend Yield | - |
Shares Outstanding | 21.08M |
Average Volume (1 week) | 117.52k |
Average Volume (1 Month) | 140.73k |
52 Week Change | 44.83% |
52 Week High | 70.81 |
52 Week Low | 44.27 |
Spread (Intraday) | 3.46 (5.1%) |
Company Name | ANI Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.anipharmaceuticals.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions